Apr 09, 2026 04:23 PM
PODCAST
Darers & Doers Podcast: The Quest for AI-Powered Cancer Vaccines
Apr.09.2026
Likang Life Sciences founder Chen Li explains how his Beijing startup is developing personalized mRNA cancer vaccines and why China’s biotech rise matters globally
00:00/00:00
Cancer treatment has long relied on a largely fixed set of options: surgery, radiation, chemotherapy and targeted drugs. But a new generation of biotech founders is trying to push the field toward something more precise — treatments built around the biology of a single patient.
In this debut episode of Darers & Doers, a special segment of the China Business Uncovered podcast, Likang Life Sciences Founder and CEO Chen Li explains how his Beijing-based biotech startup is using artificial intelligence to develop personalized mRNA cancer vaccines.
Share this article
Open WeChat and scan the QR code
MORE WAYS TO LISTEN
MOST POPULAR
- 1Chinese Retail Rush for U.S. Tech Stocks Drains Fresh Offshore Quotas
- 2Cover Story: The Gray Market Behind a Cross-Border Investing Boom
- 3China’s Investment Slump Deepens as Property Drag Overshadows Tech Shift
- 4Shenzhen Land Sale Draws Strong Bidding Despite Tighter Rules
- 5Analysis: China Adopts Market-Driven Solution to Stale Loan Rate Benchmark
SPONSORED
- 1Power To The People: Pintec Serves A Booming Consumer Class
- 2Largest hotel group in Europe accepts UnionPay
- 3UnionPay mobile QuickPass debuts in Hong Kong
- 4UnionPay International launches premium catering privilege U Dining Collection
- 5UnionPay International’s U Plan has covered over 1600 stores overseas




